Nutritional status and adherence to the mediterranean diet in children with epilepsy

Gülşah Kaner1, Gamze Yurtdaş Depboylu1, Gamze Çalık1

  • 1Department of Nutrition and Dietetics, İzmir Katip Çelebi University, İzmir, Turkiye.

Insights

Children with epilepsy often have moderate adherence to the Mediterranean diet. The Mediterranean Diet Quality Index (KIDMED) can assess healthy eating habits in this population.

Area of Science:

  • Pediatric Neurology
  • Nutritional Science
  • Dietary Assessment

Background:

  • Epilepsy in children can impact nutritional status.
  • Understanding dietary patterns is crucial for managing childhood epilepsy.
  • The Mediterranean diet is a recognized healthy eating pattern.

Purpose of the Study:

  • To assess the nutritional status of children with epilepsy.
  • To evaluate adherence to the Mediterranean diet in this cohort.
  • To explore the relationship between diet and health indicators.

Main Methods:

  • Cross-sectional study of 85 children (aged 2-18) with epilepsy.
  • Collected socio-demographic, dietary, biochemical, lifestyle, and anthropometric data.
  • Assessed Mediterranean diet adherence using the Mediterranean Diet Quality Index (KIDMED).

Main Results:

  • 15.3% of children were overweight and 15.3% were obese.
  • High adherence to the Mediterranean diet correlated with higher iron and sodium intake.
  • Higher KIDMED scores were associated with increased intake of carbohydrates, fiber, and minerals.
  • No significant relationship found between KIDMED scores and seizure frequency or anthropometrics.

Conclusions:

  • Most children with epilepsy exhibited moderate adherence to the Mediterranean diet.
  • The KIDMED index is a potentially useful tool for evaluating dietary habits in children with epilepsy.
  • Dietary assessment is important for children with epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
316
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
549
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
485
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
95
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
311